Filter
235
Text search:
dexaméthasone
Featured
Recommendations
37
New Publications
51
Language
Document type
No document type
111
Guidelines
73
Studies & Reports
21
Manuals
10
Training Material
7
Fact sheets
5
Strategic & Response Plan
4
Resource Platforms
2
Situation Updates
1
Infographics
1
Countries / Regions
India
26
Ethiopia
9
Nepal
8
Kenya
8
Rwanda
7
Germany
5
Indonesia
5
Mozambique
5
Global
5
Guinea-Bissau
4
Uganda
4
South Africa
4
Bangladesh
4
Brazil
4
Angola
4
Latin America and the Carribbean
4
Liberia
3
Nigeria
3
Cameroon
3
Tanzania
3
Myanmar / Burma
3
West and Central Africa
3
Russia
3
Senegal
2
Congo, Democratic Republic of
2
Ghana
2
Zimbabwe
2
Haiti
2
South Sudan
2
Zambia
2
Syria
2
Malawi
2
Argentina
2
Namibia
2
East and Southern Africa
2
Middle East and North Africa
2
Africa
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Philippines
1
Cambodia
1
Gambia
1
Malaysia
1
Eswatini/ Swaziland
1
Botswana
1
Libya
1
Madagascar
1
Yemen
1
Eastern Europe and Central Asia
1
Paraguay
1
Fiji
1
Solomon Islands
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
39
Women & Child Health
14
Public Health
2
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
55
Pharmacy
25
TB
13
Mental Health
6
Conflict
4
NTDs
4
Rapid Response
3
HIV
3
Global Health Education
3
AMR
3
Caregiver
3
Planetary Health
2
Disability
1
Ebola
1
Health Financing Toolbox
1
NCDs
1
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Standard Treatment Guidelines
16.7.2021
4th Edition 2018
National Malaria Elimination & Aedes Transmitted Disease Control Program
Disease Control Unit Directorate General of Health Services
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud
...
Updated July 3, 2020
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
IBOGA Review No.1 Revue Scientifique du Jésuites d'Afrique de l'Ouest
This report presents three scenarios on the impact of COVID-19 in Africa using economic growth forecasts, mortality and efforts to ameliorate impact through social grants. Likely effects are examined on per capita income, poverty and the attainment of selected Sustainable Development Goals targets.
...
Erfahrungen im Umgang mit COVID-19-Erkrankten–Hinweise von Klinikern für Kliniker –
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients
...
General practitioners and pediatricians must know the signs and
symptoms of possible pediatric cancer.
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
